Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Blocking certain proteins on immune cells may help treat alopecia areata.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Similar treatments might work for different types of scarring hair loss.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

A temporary capillary cell type helps skin repair after radiation by promoting blood vessel growth.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Phototherapy can improve various types of hair loss with minimal side effects, but more research is needed to optimize treatment.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.